Drugs are used for the treatment of asthma in patients aged 12 years and older who are uncontrolled on an inhaled corticosteroid or whose disease severity clearly warrants the use of an ICS/long-acting beta2-adrenergic agonist combination.
Generic Drugs & Pharmacy News
Japanese generic pharmaceutical manufacturer Sawai Pharmaceutical will purchase the assets and plans a major expansion in the U.S. market.
According to Argentum, the agreement generally provides that Argentum may commence marketing its generic equivalent product sometime prior to the expiration of the patents covering Restasis.
Vilazodone hydrochloride tablets, the therapeutic equivalent to the reference-listed drug product Viibryd tablets of Forest Labs, treats depression.
Daewoong Pharmaceutical’s Meroprenem is a generic of Merem, developed by AstraZeneca, as a Carbapenem-series antibiotic widely used in hospitals to treat various ailments ranging from bacterial infections to general diseases.
In fact, J&J stated is now including the estimated impact of the Actelion transaction in its financial guidance.
The New York Times is reporting that Philadephia-based generics company Lannett continues to raise prices on its drugs, even as the Justice Department is set to launch an anitrust investigations an Connecticut’s attorney general undertakes a drug price investigation into the company. Among the generics that have seen prices increase recently was anti-psychotic fluphenazine, which went from $43.50 to $870 for 100 10-mg capsules in 2016. (New York Times)
It is uncertain if the United States will attempt a similar tactic, but Trump Administration office have repeatedly said they want to lower drug prices by having the Food and Drug Administration approve generic drugs faster.
Baxter anticipates launching seven to nine new products annually over the next few years, increasing to 10 to 15 anticipated new product launches a year beyond 2019.